• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

In a hurry to develop drugs? Here’s your cHAT

Bioengineer by Bioengineer
October 30, 2020
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Rice chemists pitch ‘green’ method for making pharmaceutical intermediates

IMAGE

Credit: West Laboratory/Rice University

HOUSTON – (Oct. 30, 2020) – Let’s call it the Texas two-step, but for molecules.

Rice University scientists have developed a method to reduce alkenes, molecules used to simplify synthesis, to more useful intermediates for drugs and other compounds via a dual-catalyst technique known as cooperative hydrogen atom transfer, or cHAT.

The process enables the hydrogenation of alkenes, hydrocarbons that contain a carbon-carbon double bond, in a simpler and more environmentally friendly way.

The work by Rice chemist Julian West and postdoctoral researcher Padmanabha Kattamuri is detailed in the Journal of the American Chemical Society.

In each step, a catalyst contributes a single electron and a proton. The cHAT twist is that both reactions happen in one synergistic process, the second catalyst taking over as soon as the first is done.

“The fundamental reaction of hydrogenation is super useful for making molecules,” said West, who joined Rice last year with funding from the Cancer Prevention and Research Institute of Texas (CPRIT). “There are a few elements that are really good at this, and can do a lot of different transformations, but they’re very expensive and not the most sustainable.”

Because cHAT employs Earth-abundant iron and sulfur as catalysts, it costs far less than industry-standard methods that rely on expensive noble metals like platinum, palladium, gold and silver, as well as hydrogen gas and oxidizing reagents that create toxic waste.

The goal is to make hydrogen atoms more available to react with other molecules of choice to form new compounds. The cHAT process employs no added oxidants, works with a variety of substrates and is highly scalable. The dual-catalyst approach also serves to produce hydrogenation diastereomers, or a different form of the same product molecule that can’t be made with noble metals.

West used a baseball analogy to describe cHAT. “If you remember ‘Moneyball,’ you know that instead of trying to hire one superstar who can do everything but is really expensive, it’s better to get a few bit players and have them work together to achieve a similar transformation,” he said.

“Furthermore, through teamwork, we introduced a strategy to get us to new variations of our products as well,” West said. “By combining dirt-cheap iron with an organic sulfur compound, we were able to cobble together a nice win-win. The iron catalyst tees up the process by giving it one hydrogen atom, and gets out of the way. Then the sulfur can come in and give it the second one.”

He noted flammable hydrogen gas is a common reagent in industrial hydrogenation. “Our process uses this simple, bench-stable reagent, phenylsilane, as a hydrogen source,” West said. “We just add it to ethanol with both catalysts and the alkene. And ethanol is a green solvent as well.

“And when you’re making drugs on the ton scale you want to avoid generating tons of toxic solvent waste,” he said. “That’s something to avoid at all costs. So this could be a big win for pharmaceutical companies.”

He said his lab is working to configure its catalysts to produce a variety of products. “That would give us a lot of chemical complexity and diversity from a single starting material,” West said. “We want to know if we can exert this high level of control over the process.”

###

West is a CPRIT Scholar, the Norman Hackerman-Welch Young Investigator and an assistant professor of chemistry. CPRIT and Rice supported the research.

Read the abstract at https://pubs.acs.org/doi/10.1021/jacs.0c09544.

This news release can be found online at https://news.rice.edu/2020/10/30/in-a-hurry-to-develop-drugs-heres-your-chat/

Follow Rice News and Media Relations via Twitter @RiceUNews.

Related materials:

Rice scientists simplify the incorporation of nitrogen into molecules: https://news.rice.edu/2017/07/12/rice-scientists-simplify-the-incorporation-of-nitrogen-into-molecules-2/

West Laboratory: https://www.westchem.org

Department of Chemistry: https://chemistry.rice.edu

Wiess School of Natural Sciences: https://www.rice.edu

Images for download:

https://news-network.rice.edu/news/files/2020/10/1026_HYDROGEN-1-WEB.jpg

Rice University scientists develop cHAT to simplify the reduction of alkenes to more useful intermediate molecules for drugs and other useful chemical compounds. (Credit: West Laboratory/Rice University)

https://news-network.rice.edu/news/files/2020/10/1026_HYDROGEN-2-WEB.jpg

CAPTION: Julian West. (Credit: Rice University)

https://news-network.rice.edu/news/files/2020/10/1026_HYDROGEN-3-WEB.jpg

CAPTION: Padmanabha Kattamuri. (Credit: Rice University)

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,978 undergraduates and 3,192 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 1 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger’s Personal Finance.

Media Contact
Jeff Falk
[email protected]

Original Source

https://news.rice.edu/2020/10/30/in-a-hurry-to-develop-drugs-heres-your-chat/

Related Journal Article

http://dx.doi.org/10.1021/jacs.0c09544

Tags: Chemistry/Physics/Materials SciencesPharmaceutical SciencesPharmaceutical/Combinatorial Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Serum Markers Predict Atrial Fibrillation in Diabetes

August 2, 2025
blank

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

August 2, 2025

Mapping the Human Hippocampus: Single-Nucleus to Spatial Transcriptomics

August 2, 2025

Boosting ADMET Predictions for Key CYP450s

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    45 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Serum Markers Predict Atrial Fibrillation in Diabetes

Intrapleural Anti-VEGF Boosts Nab-Paclitaxel Efficacy

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.